• Conditions and diseases

  • Blood and immune system •
  • Cancer •
  • Cardiovascular •
  • Central nervous system •
  • Digestive system •
  • Ear and nose •
  • Endocrine, nutritional and metabolic •
  • Eye •
  • Gynaecology, pregnancy and birth •
  • Infectious diseases •
  • Injuries, accidents and wounds •
  • Mental health and behavioural conditions •
  • Mouth and dental •
  • Musculoskeletal •
  • Respiratory •
  • Skin •
  • Urogenital

• Public health

  • Accidents and injuries •
  • Alcohol •
  • Behaviour change •
  • Cancer •
  • Cardiovascular disease •
  • Child health •
  • Child social care •
  • Chronic illness •
  • Diabetes •
  • Drugs •
  • Environmental health •
  • Infectious diseases •
  • Maternal health •
  • Mental health •
  • Non-communicable diseases •
  • Obesity and diet •
  • Occupational health •
  • Older people •
  • Physical activity •
  • Sexual health •
  • Smoking and tobacco •
  • Transport •
  • Vaccine preventable diseases •
  • Working with and involving communities

• Treatments, Procedures and Devices

  • Bones and joint surgery •
  • Cardiovascular surgery •
  • Cardiovascular system drug treatments •
  • Clinical devices •
  • Diagnostic imaging •
  • Diagnostic procedures •
  • Digestive tract and other abdominal organs surgery •
  • Drug treatments •
  • Endocrine system and breast surgery •
  • Eye surgery •
  • Nervous system surgery •
  • Radiotherapy •
  • Screening •
  • Surgical procedures •
  • Therapeutic procedures •
  • Tissue and organ donation •
  • Urogenital surgery

• Guidance by type

  • Clinical Guidelines •
  • Technology appraisals •
  • Public health guidance •
  • Diagnostics guidance •
  • Interventional procedures guidance •
  • Medical technologies guidance •
  • Cancer service guidance •
  • Quality standards

• Guidance by date

  • View the guidance by date published

About NICE guidance Close

Navigation

• NICE guidance

• Find guidance
• NICE Pathways
• Latest guidance
• Guidance by type
• Guidance in development
• How guidance is produced
• NICE guidance research recommendations
• Guidance for patients and public
• Other publications
• Patient safety solutions pilot
• Quality standards

CardioQ-ODM (oesophageal Doppler monitor) to guide intravenous fluid management in patients undergoing surgery, or in critical care

Status:	History
Expected date of issue:	TBC
Notification date:	March 2010
Topic area: Surgical procedures Therapeutic procedures

Project team | Schedule | Stakeholders | Project history | Key documents

 

NICE project team

Patient Involvement Lead:	Laura Norburn
Analyst:	Bernice Dillon
Communications Lead:	Tonya Gillis
Project manager:	Marlon Hope
Implementation Lead:	Alaster Rutherford

Top

 

Provisional schedule

Submission Date Text:	TBC
Topic Selection:	19 March 2010
Draft guidance meeting	16 September 2010
Consultation opens:	04 October 2010
Consultation ends:	01 November 2010
Final guidance meeting:	18 November 2010

Top

 

Stakeholders

To be confirmed

Top

 

Project history

Date Update 7 March 2011 The NICE resolution panel have met. 26 January 2011 As a final quality assurance step, and to ensure that NICE acts fairly, those who responded to the consultation guidance are offered access, having first completed a confidentiality form, to the prepublication final guidance and to the (anonymised) consultation comments. The purpose of this process is to identify errors or breaches of process before publication. Respondents are asked to specify which of these two grounds they are requesting resolution on. In case of the CardioQ ODM guidance, one or more resolution requests was received which, after initial scrutiny, has been referred by the Centre for Health Technology Evaluation Director to a resolution panel. The resolution panel will be convened in line with Section 6 of the Process Guide. Please note that the resolution panel does not meet in public but that those making resolution requests are informed of the outcome of resolution before guidance is published. Further information, including updates on the expected guidance publication date, will be added to this web page as soon as it is available. The Programme's Process and Methods Guides are available on the Evaluation Pathway Programme for Medical Technologies web page.

Top

 

Key documents

CardioQ-ODM (oesophageal Doppler monitor) to guide intravenous fluid management in patients undergoing surgery, or in critical care: Equality impact assessment 18 August 2011 CardioQ-ODM (oesophageal Doppler monitor) to guide intravenous fluid management in patients undergoing surgery, or in critical care: medical technologies consultation 04 October 2010 NICE draft guidance on cardiac output monitoring device published for consultation: press release 04 October 2010

This page was last updated: 15 November 2011